LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,195 | -37.4% | 31,372 | +31.5% | 0.00% | – |
| Q2 2023 | $54,626 | +2.8% | 23,854 | +9.1% | 0.00% | – |
| Q1 2023 | $53,151 | +30.6% | 21,873 | +2.7% | 0.00% | – |
| Q4 2022 | $40,685 | -15.2% | 21,301 | +6.7% | 0.00% | – |
| Q3 2022 | $48,000 | +60.0% | 19,957 | +23.1% | 0.00% | – |
| Q2 2022 | $30,000 | -11.8% | 16,216 | +0.7% | 0.00% | – |
| Q1 2022 | $34,000 | -44.3% | 16,100 | +3.5% | 0.00% | – |
| Q4 2021 | $61,000 | -19.7% | 15,554 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $76,000 | +5.6% | 15,732 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +227.3% | 15,696 | +39.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |